Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Roche acquires Innovatis AG to complement cellular analytics portfolio
April 2009
SHARING OPTIONS:

BASEL, Switzerland—Roche announced last month that it has signed a definite agreement under which Roche will acquire 100 percent of automated cell analysis solutions provider Innovatis AG, a privately held company based in Bielefeld, Germany, for $19.4 million. Innovatis will become a fully-integrated part of Roche Applied Science, a global business area of the diagnostic division of Roche. The company will continue to develop and market products for cell analysis through Roche Applied Science's extensive worldwide network. Innovatis' focus on cell counting, viability testing, cell function analysis in research and bioproduction will complement Roche's cell analysis portfolio, says Dr. Jürgen Schwiezer, CEO of Roche's diagnostic division, adding that the acquisition is synergistic to the xCELLigence technology launched in 2008.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.